BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao J, Hou Y, Yin C, Hu J, Gao T, Huang X, Zhang X, Xing J, An J, Wan S, Li J. Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma. Oncogene 2020;39:1724-38. [PMID: 31740780 DOI: 10.1038/s41388-019-1093-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Cornwell AC, Feigin ME. Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype. Trends Pharmacol Sci 2020;41:1006-22. [PMID: 33198923 DOI: 10.1016/j.tips.2020.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Han L, Lin X, Yan Q, Gu C, Li M, Pan L, Meng Y, Zhao X, Liu S, Li A. PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells. Oncogene 2022. [PMID: 35140333 DOI: 10.1038/s41388-022-02197-x] [Reference Citation Analysis]
3 Chou SE, Lee KL, Wei PK, Cheng JY. Screening anti-metastasis drugs by cell adhesion-induced color change in a biochip. Lab Chip 2021;21:2955-70. [PMID: 34132296 DOI: 10.1039/d1lc00039j] [Reference Citation Analysis]
4 Qiu W, Wang Z, Chen R, Shi H, Ma Y, Zhou H, Li M, Li W, Chen H, Zhou H. Xiaoai Jiedu Recipe suppresses hepatocellular carcinogenesis through the miR-200b-3p /Notch1 axis. Cancer Manag Res 2020;12:11121-31. [PMID: 33173345 DOI: 10.2147/CMAR.S269991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang Y, Li L, Liu R, Zeng C. DNA Primase Subunit 1 Expression in Hepatocellular Carcinoma and Its Clinical Implication. Biomed Res Int 2020;2020:9689312. [PMID: 32908930 DOI: 10.1155/2020/9689312] [Reference Citation Analysis]
6 Pham L, Kennedy L, Baiocchi L, Meadows V, Ekser B, Kundu D, Zhou T, Sato K, Glaser S, Ceci L, Alpini G, Francis H. Mast cells in liver disease progression: An update on current studies and implications. Hepatology 2022;75:213-8. [PMID: 34435373 DOI: 10.1002/hep.32121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ning J, Ye Y, Bu D, Zhao G, Song T, Liu P, Yu W, Wang H, Li H, Ren X, Ying G, Zhao Y, Yu J. Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness. Mol Ther 2021;29:2067-87. [PMID: 33601054 DOI: 10.1016/j.ymthe.2021.02.016] [Reference Citation Analysis]
8 Li H, Li Y, Tian D, Zhang J, Duan S. miR-940 is a new biomarker with tumor diagnostic and prognostic value. Mol Ther Nucleic Acids 2021;25:53-66. [PMID: 34168918 DOI: 10.1016/j.omtn.2021.05.003] [Reference Citation Analysis]
9 Zhu Q, Zhuang XX, Chen JY, Yuan NN, Chen Y, Cai CZ, Tan JQ, Su HX, Lu JH. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models. Phytomedicine 2021;87:153578. [PMID: 34038839 DOI: 10.1016/j.phymed.2021.153578] [Reference Citation Analysis]
10 Peng J, Duan Z, Guo Y, Li X, Luo X, Han X, Luo J. Identification of candidate biomarkers of liver hydatid disease via microarray profiling, bioinformatics analysis, and machine learning. J Int Med Res 2021;49:300060521993980. [PMID: 33787392 DOI: 10.1177/0300060521993980] [Reference Citation Analysis]
11 Sharma A, Upadhyay V, Sarkar M, Mishra M, Thacker G, Trivedi AK. Proteomic analysis of TGFβ-induced A549 secretome identifies putative regulators of epithelial-mesenchymal transition. Biotechnol Appl Biochem 2021. [PMID: 33559923 DOI: 10.1002/bab.2121] [Reference Citation Analysis]
12 Nguyen PL, Cho J. Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets. Biomolecules 2021;11:1232. [PMID: 34439898 DOI: 10.3390/biom11081232] [Reference Citation Analysis]
13 Czerwiński M, Bednarska-Czerwińska A, Zmarzły N, Boroń D, Oplawski M, Grabarek BO. Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer. J Clin Med 2021;10:4872. [PMID: 34768392 DOI: 10.3390/jcm10214872] [Reference Citation Analysis]
14 Sarasola MP, Táquez Delgado MA, Nicoud MB, Medina VA. Histamine in cancer immunology and immunotherapy. Current status and new perspectives. Pharmacol Res Perspect 2021;9:e00778. [PMID: 34609067 DOI: 10.1002/prp2.778] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Shen YC, Hsu HC, Lin TM, Chang YS, Hu LF, Chen LF, Lin SH, Kuo PI, Chen WS, Lin YC, Chen JH, Liang YC, Chang CC. H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection. J Clin Oncol 2022;:JCO2101802. [PMID: 35044851 DOI: 10.1200/JCO.21.01802] [Reference Citation Analysis]
16 Zhang C, Yu Y, Ma L, Fu P. Histamine H3 Receptor Promotes Cell Survival via Regulating PKA/CREB/CDKN1A Signal Pathway in Hepatocellular Carcinoma. Onco Targets Ther 2020;13:3765-76. [PMID: 32440145 DOI: 10.2147/OTT.S250655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sadeghi Rad H, Monkman J, Warkiani ME, Ladwa R, O'Byrne K, Rezaei N, Kulasinghe A. Understanding the tumor microenvironment for effective immunotherapy. Med Res Rev 2021;41:1474-98. [PMID: 33277742 DOI: 10.1002/med.21765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
18 Liang S, Zhang X, Li J. Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma. Bioengineered 2022;13:7367-79. [PMID: 35297315 DOI: 10.1080/21655979.2022.2040827] [Reference Citation Analysis]